We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSR
176
DELISTED
Fisker Inc.
FSR
| $53.1M | 0.14% |
4,952,000
| – | – |
|
177
US Bancorp
USB
$98.7B
| $52.8M | 0.14% |
+1,433,800
| New | +$51.1M |
|
178
Moody's
MCO
$82.8B
| $51.4M | 0.13% |
187,075
+55,900
| +43% | +$14.2M |
|
179
Zebra Technologies
ZBRA
$13.9B
| $51.2M | 0.13% |
200,111
-4,689
| -2% | -$1.1M |
|
180
General Motors
GM
$79.3B
| $50.8M | 0.13% |
2,008,948
+379,662
| +23% | +$9.24M |
|
181
Teleflex
TFX
$6.26B
| $50.5M | 0.13% |
138,821
+86,700
| +166% | +$30M |
|
182
General Dynamics
GD
$103B
| $50.4M | 0.13% |
337,020
-7,053
| -2% | -$996K |
|
183
Automatic Data Processing
ADP
$108B
| $50.2M | 0.13% |
337,076
-13,100
| -4% | -$1.88M |
|
184
Edwards Lifesciences
EW
$50.9B
| $49.4M | 0.13% |
714,951
-267,750
| -27% | -$19M |
|
|
WPX
185
DELISTED
WPX Energy, Inc.
WPX
| $49.3M | 0.13% |
7,721,800
-13,029,543
| -63% | -$73.5M |
|
|
BMY.RT
186
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $49.1M | 0.13% |
13,715,841
+550,000
| +4% | +$1.98M |
|
187
Estee Lauder
EL
$30.5B
| $49M | 0.13% |
259,684
+153,408
| +144% | +$27.4M |
|
|
PRNB
188
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $49M | 0.13% |
819,160
-45,840
| -5% | -$2.83M |
|
189
Johnson Controls International
JCI
$88.9B
| $48.9M | 0.13% |
+1,433,629
| New | +$44.1M |
|
190
Motorola Solutions
MSI
$72.7B
| $48.4M | 0.12% |
345,594
-57,582
| -14% | -$8.15M |
|
191
Progressive
PGR
$122B
| $48.4M | 0.12% |
603,685
-217,519
| -26% | -$17M |
|
192
AES
AES
$10.5B
| $47.7M | 0.12% |
3,288,533
+2,536,700
| +337% | +$33.3M |
|
|
193
Lockheed Martin
LMT
$134B
| $47.5M | 0.12% |
130,200
-897,077
| -87% | -$339M |
|
194
KeyCorp
KEY
$24.3B
| $47M | 0.12% |
3,857,549
-1,607,439
| -29% | -$18.7M |
|
195
OneMain Financial
OMF
$7.42B
| $46.7M | 0.12% |
1,903,502
+387,802
| +26% | +$8.83M |
|
|
GRA
196
DELISTED
W.R. Grace & Co.
GRA
| $46.5M | 0.12% |
914,525
-163,700
| -15% | -$7.75M |
|
|
PE
197
DELISTED
PARSLEY ENERGY INC
PE
| $46.3M | 0.12% |
4,333,587
-6,779,700
| -61% | -$62.8M |
|
198
Truist Financial
TFC
$62.9B
| $45.8M | 0.12% |
1,220,025
-325,349
| -21% | -$11.7M |
|
199
Westlake Corp
WLK
$8.94B
| $45.3M | 0.12% |
844,068
-367,200
| -30% | -$16.9M |
|
200
DuPont de Nemours
DD
$18.8B
| $45.2M | 0.12% |
678,326
-634,067
| -48% | -$37M |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.